Last reviewed · How we verify

NCT04044911: CogWatchTea

Trial Using CogWatch for Tea Making Training in Stroke Apraxia and Action Disorganisation Syndrome

Completed NA Last updated 7 August 2019
What this trial tests

NA trial testing Task model (CogWatch) in Stroke in 29 participants. Completed in 4 December 2014.

Timeline
1 June 2014
Primary endpoint
4 December 2014
4 December 2014

Quick facts

Lead sponsorUniversity of Birmingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment29
Start date1 June 2014
Primary completion4 December 2014
Estimated completion4 December 2014

Drugs / interventions tested

Conditions studied

Sponsor

University of Birmingham

Who can join

Adults 18 to 90, any sex, with Stroke or Apraxias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Apraxia and action disorganization syndrome after stroke can disrupt activities of daily living (ADL). Occupational therapy has been effective in improving ADL performance, however, inclusion of multiple tasks means it is unclear which therapy elements contribute to improvement. This study evaluates the efficacy of a task model approach to ADL rehabilitation, comparing training in making a cup of tea with a gait training control condition.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The efficacy of a task model approach to ADL rehabilitation in stroke apraxia and action disorganisation syndrome: A randomised controlled trial.
    Howe J, Chua W, Sumner E, Drozdowska B, et al · · 2022 · cited 4× · PMID 35239707 · DOI 10.1371/journal.pone.0264678

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04044911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing